Skip to content

Company information lookup

PRANA BIOTECHNOLOGY LIMITED (PBT)

The Company's business is the development of therapeutic drugs for age-related diseases.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PBT 0.205 -2.38% 0.205 0.215 0.210 0.210 0.205 30,644

PRANA BIOTECHNOLOGY LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PBT
Securities
Official Listing Date 28 March, 2000
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.pranabio.com
Registered Office Address Suite 2, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3143
Head Office Telephone (03) 8692 9048
Head Office Fax (03) 8692 9040
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Geoffrey Kempler (Executive Chairman)
Mr Peter Marks (Director)
Prof. Ira Shoulson (Director)
Mr Lawrence Gozlan (Non Exec. Director)
Mr Brian Meltzer (Non Exec. Director)
Dr George Mihaly (Non Exec. Director)
Ms Dianne Angus (Chief Op. Officer)
Mr Richard Revelins (CFO)
Company Secretary Mr Richard Revelins
Principal Activities The Company's business is the development of therapeutic drugs for age-related diseases.

PRANA BIOTECHNOLOGY LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
30/10/2014 asterix Appendix 4C - quarterly 5 PDF
24/10/2014   AGM Resolution 4 Withdrawn 1 PDF
13/10/2014   Notice of Annual General Meeting/Proxy Form 20 PDF
03/10/2014   Appendix 3B 11 PDF
30/09/2014   Annual Report to shareholders 116 PDF
05/09/2014 asterix FDA Orphan Drug Designation for PBT2 for Huntington Disease 2 PDF
05/09/2014 asterix Trading Halt 2 PDF
29/08/2014 asterix Appendix 4E & Preliminary Final Report 27 PDF
07/08/2014   Appendix 3B and 708A notice 12 PDF
31/07/2014 asterix Appendix 4C - quarterly 5 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
31 Oct 2014 0.205 -2.38% 0.210 0.205 30,644
30 Oct 2014 0.210 0% 0.210 0.210 21,836
29 Oct 2014 0.210 0% 0.215 0.210 51,186
28 Oct 2014 0.210 -6.67% 0.210 0.210 50,500
27 Oct 2014 0.225 2.27% 0.225 0.220 35,969

* Volume of shares shown represents only those shares traded on ASX.

PRANA BIOTECHNOLOGY LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PBT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PBT

Warrants & Structured Products

No warrants & Structured Products are available over the security PBT